Table 1 Tumour Characteristics
Tumour Characteristic | All Breast Cancers N = 89 | Premenopausal Breast Cancer N = 25 | Postmenopausal Breast Cancer N = 64 | p-value |
|---|---|---|---|---|
Histologic Subtype | Â | Â | Â | Â |
-Invasive Ductal (%) | 67(75) | 19(76) | 48(75) | Â |
-Invasive Lobular (%) | 12(13.5) | 3(12) | 9(14) | 0.1 |
-DCIS (%) | 4(4.5) | 0 | 4(6) | Â |
-Other (%) | 6(7) | 3(12) | 3(5) | Â |
Median tumor size (IQR) mm | 25 (16–35) | 28 (15–36) | 24.5 (16.25–35) | 0.955 |
Lymph node +ve (n)(%) | 49 (55) | 16(66) | 33(52) | 0.347 |
Receptor Status | Â | Â | Â | Â |
-ER Positive (%) | 78 (88) | 24(96) | 54(84) | 0.056 |
-PR Positive (%) | 81(91) | 24(96) | 57(89) | 0.117 |
-Her2neu Positive (%) | 15(17) | 3(12) | 12(19) | 0.47 |
Tumor Grade | Â | Â | Â | Â |
-Grade 1 (%) | 19(21) | 8(32) | 11(17) | Â |
-Grade 2 (%) | 43(48) | 10(40) | 33(52) | 0.183 |
-Grade 3 (%) | 27(31) | 7(28) | 20(31) | Â |
UICC Stage | Â | Â | Â | Â |
-Stage 0 in-situ (%) | 4(4) | 0 | 4(6) | Â |
-Stage 1 (%) | 19(21) | 5(20) | 14(22) | Â |
-Stage 2a (%) | 21(24) | 7(28) | 14(22) | 0.657 |
-Stage 2b (%) | 26(29) | 9(36) | 17(27) | Â |
-Stage 3a (%) | 13(15) | 2(8) | 11(17) | Â |
-Stage 3b (%) | 6(7) | 2(8) | 4(6) | Â |